Antoun Nabhan
Corporate Officer/Principal bei Sagamore China Partners I LP
Aktive Positionen von Antoun Nabhan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sagamore China Partners I LP
 Sagamore China Partners I LP Investment ManagersFinance Sagamore China Partners I LP invests in the biotechnology & healthcare companies across the globe, primarily in the US, China and Singapore. The fund targets companies operating in the fields of therapeutics, medical devices, diagnostics and infectious diseases. It provides financing for start-up and growth companies. | Corporate Officer/Principal | 01.01.2002 | - |
OCM Distressed Debt Group
 OCM Distressed Debt Group Investment ManagersFinance OCM Distressed Debt Group (OCM) is an private equity firm founded in 1995 by Bruce Allen Karsh and Sheldon Michael Stone. The firm is an operating division of Oaktree Capital Management LP. The firm is headquartered in Los Angeles. | Private Equity Investor | 01.11.2020 | - |
Karriereverlauf von Antoun Nabhan
Ehemalige bekannte Positionen von Antoun Nabhan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PEAR THERAPEUTICS, INC. | Private Equity Investor | 01.09.2017 | 01.11.2020 |
Establishment Labs SA
 Establishment Labs SA Medical SpecialtiesHealth Technology Establishment Labs SA is a medical device and aesthetics firm. It designs, develops, manufactures, and ,markets advanced silicon-filled breast and body shaping implants. The company was founded by Juan José Chacon Quiros in 2004 and is headquartered in Alajuela, Costa Rica. | Finanzdirektor/CFO | 01.05.2016 | 01.05.2017 |
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.04.2014 | 17.12.2014 |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 20.04.2012 | - |
Deloitte Consulting LLP
 Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Heller Ehrman LLP
 Heller Ehrman LLP Miscellaneous Commercial ServicesCommercial Services Heller Ehrman LLP provides legal services. It offers litigation, business, and intellectual property services. The company was founded in 1980 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Finanzdirektor/CFO | 01.03.2006 | - |
| Gründer | 01.03.2006 | - | |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Antoun Nabhan
| The University of Chicago | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 13 |
| Costa Rica | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Director of Finance/CFO | 3 |
| Founder | 2 |
Sektoral
| Health Technology | 7 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SOLENO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Heller Ehrman LLP
Heller Ehrman LLP Miscellaneous Commercial ServicesCommercial Services Heller Ehrman LLP provides legal services. It offers litigation, business, and intellectual property services. The company was founded in 1980 and is headquartered in San Francisco, CA. | Commercial Services |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Deloitte Consulting LLP
Deloitte Consulting LLP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LLP provides business consulting services. It offers services related to public finance, public sector management, health and social protection, information technology, financial sector, and trade and investment. The company was founded in 1996 and is headquartered in New York, NY. | Commercial Services |
OCM Distressed Debt Group
OCM Distressed Debt Group Investment ManagersFinance OCM Distressed Debt Group (OCM) is an private equity firm founded in 1995 by Bruce Allen Karsh and Sheldon Michael Stone. The firm is an operating division of Oaktree Capital Management LP. The firm is headquartered in Los Angeles. | Finance |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
| Incellico, Inc. | |
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
Sagamore China Partners I LP
Sagamore China Partners I LP Investment ManagersFinance Sagamore China Partners I LP invests in the biotechnology & healthcare companies across the globe, primarily in the US, China and Singapore. The fund targets companies operating in the fields of therapeutics, medical devices, diagnostics and infectious diseases. It provides financing for start-up and growth companies. | Finance |
Establishment Labs SA
Establishment Labs SA Medical SpecialtiesHealth Technology Establishment Labs SA is a medical device and aesthetics firm. It designs, develops, manufactures, and ,markets advanced silicon-filled breast and body shaping implants. The company was founded by Juan José Chacon Quiros in 2004 and is headquartered in Alajuela, Costa Rica. | Health Technology |
Pear Therapeutics, Inc.
 Pear Therapeutics, Inc. Medical SpecialtiesHealth Technology Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. The company’s lead product, reSET, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Its second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear's third product, Somryst for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway while simultaneously reviewed through the FDA's Software Precertification Pilot Program. The company was founded on December 1, 2020 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Antoun Nabhan
- Erfahrung